EGRX — EAGLE PHARMACEUTICALS IN
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 2 SEC-registered investment managers reported holding EGRX (EAGLE PHARMACEUTICALS IN) in their latest 13F filings, with a combined reported value of $8.28K across 12.35K shares. That is +0.0% by share count (+0 shares) versus the previous quarter, while reported value moved +96.5%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Major shareholders of EAGLE PHARMACEUTICALS IN (EGRX) include ADAGE CAPITAL PARTNERS GP, L.L.C., Balyasny Asset Management, AIGH Capital Management LLC, ranked by reported 13F value among the 157 institutional holders on this page.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 2 | 12.35K | $11.73K | +0.0% |
| Q2 2026 | 2 | 12.35K | $8.28K | +0.0% |
| Q1 2026 | 2 | 12.35K | $4.21K | +0.0% |
| Q4 2025 | 2 | 12.35K | $8.64K | +0.0% |
| Q3 2025 | 2 | 12.35K | $33.34K | +0.0% |
| Q2 2025 | 2 | 12.35K | $35.81K | +0.0% |
| Q1 2025 | 2 | 12.35K | $12.10K | +0.0% |
| Q4 2024 | 8 | 71.82K | $35.83K | +16.1% |
Over the 8 quarters shown, institutional share counts decreased 83% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q4 2024 (+16.1%).
Top Institutional Holders (Q3 2026) — 2 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 12.00K | $11.40K | 0.00% | Hold | |
| 350 | $333 | 0.00% | Hold |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 2 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 12.00K | $8.04K | 0.00% | Hold | |
| 350 | $235 | 0.00% | Hold |
Q1 2026 — 2 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 12.00K | $4.09K | 0.00% | Hold | |
| 350 | $119 | 0.00% | Hold |
Q4 2025 — 2 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 12.00K | $8.40K | 0.00% | Hold | |
| 350 | $245 | 0.00% | Hold |
Q3 2025 — 2 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 12.00K | $32.40K | 0.01% | Hold | |
| 350 | $945 | 0.00% | Hold |
Q2 2025 — 2 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 12.00K | $34.80K | 0.01% | Hold | |
| 350 | $1.01K | 0.00% | Hold |
New Positions (Q2 2026)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stanley-Laman Group, Ltd. | 12.00K | 12.00K | 12.00K | 12.00K | 12.00K | 12.00K | 12.00K | 12.00K | 12.00K | 12.00K | 12.00K | 12.00K | 12.00K | — | — | — | — | — | — | — |
| Archer Investment Corp | 350 | 350 | 350 | 350 | 350 | 350 | 350 | 350 | 350 | 350 | 350 | 350 | 350 | — | — | — | — | — | — | — |
| Janus Henderson Group | — | — | — | — | — | — | — | — | — | — | — | 775.52K | 1.14M | 1.15M | 1.15M | 1.23M | 1.24M | 1.44M | 1.49M | 1.53M |
| BRANDES INVESTMENT PARTNERS, LP | — | — | — | — | — | — | — | — | — | — | — | 745.08K | 1.13M | — | — | — | — | — | — | — |
| Renaissance Technologies | — | — | — | — | — | — | — | — | 256.35K | 244.25K | 333.85K | 294.45K | 256.15K | 260.47K | 208.85K | 266.65K | 274.28K | 252.98K | 213.58K | 207.78K |
| Vanguard Group | — | — | — | — | — | — | — | — | 579.51K | 564.40K | 640.75K | 638.12K | 643.60K | 621.69K | 756.73K | 763.81K | 775.51K | 771.76K | 780.85K | 760.47K |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | — | — | — | — | — | — | — | — | — | — | — | — | 500.00K | — | — | — | — | — | — | — |
| Northern Trust Corp | — | — | — | — | — | — | — | — | 31.95K | 94.06K | 99.50K | 105.97K | 97.25K | 107.23K | 120.75K | 118.32K | 116.00K | 163.10K | 140.31K | 144.03K |
| AIGH Capital Management LLC | — | — | — | — | — | — | — | — | 1.21M | 1.21M | 1.19M | — | — | — | — | — | — | — | — | — |
| Nantahala Capital Management, LLC | — | — | — | — | — | — | — | — | 1.00M | 1.00M | 1.26M | — | — | — | — | — | — | — | — | — |
| Citigroup Inc | — | — | — | — | — | — | — | — | 1.00M | 1.00M | 2.72K | 1.75K | 203 | 6.04K | 7.41K | 33.78K | 58.39K | 27.28K | 16.11K | 35.80K |
| MILLENNIUM MANAGEMENT LLC | — | — | — | — | — | — | — | — | — | 167.78K | 257.86K | 522.40K | 347.53K | — | — | — | — | — | — | — |
| AQR CAPITAL MANAGEMENT LLC | — | — | — | — | — | — | — | — | 374.99K | 696.80K | 879.07K | 493.67K | 282.96K | — | — | — | — | — | — | — |
| DIMENSIONAL FUND ADVISORS LP | — | — | — | — | — | — | — | — | — | — | 171.09K | 246.50K | 280.69K | — | — | — | — | — | — | — |
| AMERIPRISE FINANCIAL INC | — | — | — | — | — | — | — | — | — | — | — | 25.87K | 257.48K | — | — | — | — | — | — | — |
| Geode Capital Management | — | — | — | — | — | — | — | — | 105.85K | 108.00K | 231.64K | 225.29K | 219.84K | 214.99K | 203.15K | 200.31K | 196.60K | 189.85K | 205.12K | 204.40K |
| Assenagon Asset Management S.A. | — | — | — | — | — | — | — | — | 183.59K | 185.34K | 185.34K | 217.67K | 217.67K | — | — | — | — | — | — | — |
| STATE STREET CORP | — | — | — | — | — | — | — | — | 35.82K | 35.82K | 213.67K | 222.59K | 207.77K | — | — | — | — | — | — | — |
| Allspring Global Investments Holdings, LLC | — | — | — | — | — | — | — | — | — | — | — | 3.83K | 191.63K | — | — | — | — | — | — | — |
| Morgan Stanley | — | — | — | — | — | — | — | — | 192.21K | 300.45K | 375.33K | 296.86K | 164.07K | 182.04K | 245.81K | 250.28K | 231.99K | 212.31K | 147.29K | 132.39K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold EGRX?
As of 2026-Q2, 2 institutional funds reported holding EGRX (EAGLE PHARMACEUTICALS IN) in SEC 13F filings, with a combined reported value of $8.28K.
How many shares of EGRX do institutions own?
13F filers reported 12.35K shares of EGRX, worth $8.28K in aggregate at the end of 2026-Q2.
Is institutional ownership of EGRX rising or falling?
Share counts moved +0.0% versus the prior quarter — accumulation.
Who are the top institutional holders of EGRX?
The largest 13F holders are ADAGE CAPITAL PARTNERS GP, L.L.C., Balyasny Asset Management, AIGH Capital Management LLC, Janus Henderson Group, BRANDES INVESTMENT PARTNERS, LP; the top 25 are ranked at the top of this page.
Who are the major shareholders of EAGLE PHARMACEUTICALS IN?
The major shareholders of EAGLE PHARMACEUTICALS IN (EGRX) by reported 13F value are ADAGE CAPITAL PARTNERS GP, L.L.C., Balyasny Asset Management, AIGH Capital Management LLC, Janus Henderson Group, BRANDES INVESTMENT PARTNERS, LP, among 157 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.